Kinfo
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEHealthcare·US · USD
$140.71
+1.17 (+0.84%)
Prices as of October 6, 2026 · live

Price

Key statistics

Valuation
Market cap344.27B USD
Enterprise value402.83B USD
Trailing P/E114.52
Forward P/E15.14
PEG ratio-0.88
Price / sales5.35
Price / book8.50
Profitability
Gross margin73.54%
Operating margin-0.24%
Profit margin4.77%
Return on assets11.87%
Return on equity6.96%
Income (TTM)
Revenue66.57B USD
Gross profit50.53B USD
EBITDA29.11B USD
Net income3.17B USD
Diluted EPS$1.26
Rev. growth (YoY)5.10%
Balance sheet
Total cash7.14B USD
Total debt53.91B USD
Debt / equity128.41
Current ratio1.32
Book value / share$16.99
Cash flow (TTM)
Operating cash flow19.97B USD
Levered free cash flow15.17B USD
Shares & price
Shares outstanding2.47B
Float2.46B
Held by institutions83.04%
Beta0.23
50-day MA$142.29
200-day MA$122.86
52-week high$156.92
52-week low$82.01
Dividends
Forward rate
$3.40
Yield
2.42%
Payout ratio
268.80%
Frequency
Quarterly
Recent payments
  • 2026-09-15$0.85
Earnings (EPS)
DateEst.ActualSurprise2026-08-04-0.26-0.13+50.00%2026-04-30-1.47-1.28+12.93%2026-02-16-10.85-0.59+94.56%2026-02-032.012.04+1.49%
About Merck & Co., Inc.

Merck & Co., Inc. is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing medicines, vaccines, biologic therapies, and animal health products. The company’s pharmaceutical business serves areas such as oncology, immunology, infectious diseases, cardiometabolic conditions, neuroscience, and hospital care, while its vaccine portfolio supports preventive care across pediatric, adolescent, and adult populations. Merck & Co., Inc. also operates an animal health segment that provides veterinary pharmaceuticals, vaccines, and health management solutions for livestock and companion animals. Its products are distributed through healthcare providers, wholesalers, pharmacies, hospitals, veterinarians, and government channels, giving the company a broad role across human and animal health markets. Headquartered in Rahway, New Jersey, Merck & Co., Inc. is recognized for its research-intensive model and its presence in essential therapeutic and preventive care categories worldwide.

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Robert M. Davis J.D.
Employees
73,000
Headquarters
Rahway, NJ, United States

Frequently asked questions about Merck & Co., Inc.